Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$4.40
+0.200 (+4.76%)
At Close: May 08, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0858 $8.83 Wednesday, 8th May 2024 ATXI stock ended at $4.40. This is 4.76% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 13.73% from a day low at $4.15 to a day high of $4.72.
90 days $0.0858 $8.83
52 weeks $0.0858 $8.83

Historical Avenue Therapeutics, Inc. prices

Date Open High Low Close Volume
Jan 22, 2024 $0.140 $0.147 $0.133 $0.142 3 126 908
Jan 19, 2024 $0.144 $0.146 $0.138 $0.140 1 306 820
Jan 18, 2024 $0.141 $0.146 $0.138 $0.145 989 489
Jan 17, 2024 $0.150 $0.153 $0.136 $0.143 2 801 811
Jan 16, 2024 $0.180 $0.180 $0.142 $0.155 2 758 732
Jan 12, 2024 $0.176 $0.185 $0.162 $0.174 3 547 753
Jan 11, 2024 $0.175 $0.189 $0.165 $0.174 3 298 215
Jan 10, 2024 $0.189 $0.190 $0.169 $0.174 4 321 506
Jan 09, 2024 $0.185 $0.195 $0.181 $0.189 2 938 666
Jan 08, 2024 $0.197 $0.228 $0.178 $0.195 9 322 756
Jan 05, 2024 $0.243 $0.253 $0.182 $0.190 21 609 748
Jan 04, 2024 $0.285 $0.353 $0.242 $0.342 180 167 687
Jan 03, 2024 $0.161 $0.178 $0.161 $0.175 2 083 403
Jan 02, 2024 $0.175 $0.175 $0.152 $0.160 896 702
Dec 29, 2023 $0.164 $0.171 $0.161 $0.161 282 094
Dec 28, 2023 $0.160 $0.172 $0.160 $0.165 1 151 712
Dec 27, 2023 $0.157 $0.164 $0.152 $0.163 961 198
Dec 26, 2023 $0.145 $0.167 $0.141 $0.162 2 341 761
Dec 22, 2023 $0.142 $0.150 $0.142 $0.144 619 245
Dec 21, 2023 $0.145 $0.146 $0.140 $0.141 484 570
Dec 20, 2023 $0.148 $0.150 $0.142 $0.144 706 862
Dec 19, 2023 $0.152 $0.152 $0.143 $0.144 269 092
Dec 18, 2023 $0.150 $0.155 $0.138 $0.150 1 162 420
Dec 15, 2023 $0.156 $0.160 $0.146 $0.148 1 005 083
Dec 14, 2023 $0.142 $0.151 $0.138 $0.151 895 262
Click to get the best stock tips daily for free!

About Avenue Therapeutics, Inc.

Avenue Therapeutics. Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.... ATXI Profile

Golden Star

Ticker Date Change Price
WMT May 06 0.718% $59.87
UNP May 06 2.80% $239.21
JPM May 06 1.90% $192.00
INGR May 03 3.40% $114.56
BNDX May 03 0.247% $48.68
BBCA May 03 0.99% $65.44
ADTH May 03 5.86% $3.24
ASH May 03 1.78% $95.85
INVH May 03 0.90% $34.39
INTU May 03 0.502% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT